Report: Incoming Trump executive order to eliminate ‘thousands’ of jobs at HHS

The U.S. Department of Health and Human Services (HHS) has been instructed to prepare for “thousands” of jobs to be cut at the agency as a result of an upcoming executive order from President Donald Trump, a new report claims. 

According to coverage in the Wall Street Journal, leadership at HHS has been told to rank probationary workers as the Trump Administration prepares to announce layoffs. However, for now, the still-unconfirmed order appears to apply only to probationary staff—those who have been with the agency for one or two years.

As the basis for the report, the Wall Street Journal cites anonymous internal sources, who said the edict was expected to be signed sometime next week. However, the White House denied any such executive order was coming when reporters attempted to corroborate the story.

If true, the cuts could affect all agencies under HHS, including the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), and the Centers for Medicare & Medicaid Services (CMS).

At present, HHS employs roughly 80,000 people across different agencies. It’s unclear how the potential elimination of jobs would impact healthcare services, such as Medicare and Medicaid.

The timing of the Wall Street Journal’s story follows news from earlier this week that billionaire Elon Musk’s special quasi-government taskforce, the Department of Government Efficiency (DOGE), is currently sifting through CMS payment records in search of "big money fraud."

For more, read the full coverage from the Wall Street Journal at the link below.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

American College of Cardiology President Cathie Biga, MSN, says Medicare payment reform remains a top priority going forward. Site-neutral payments and improved access to PAD screening are two other issues close to the ACC's heart. 

The FDA has already shown great interest in the drug, which is designed to help AFib patients reduce their stroke and systemic embolism risks.